Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000328605 | SCV000397193 | likely benign | Blau syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Clinical Services Laboratory, |
RCV000366926 | SCV000397194 | likely benign | Crohn disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000807310 | SCV000947357 | uncertain significance | Blau syndrome; Inflammatory bowel disease 1 | 2018-08-22 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with cysteine at codon 235 of the NOD2 protein (p.Arg235Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs104895422, ExAC 0.02%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been observed in individuals affected with Crohn's disease (CD) (PMID: 11875755, 12626759, 16278823). ClinVar contains an entry for this variant (Variation ID: 97879). Experimental studies have shown that this missense change moderately effects NOD2 protein function (PMID: 12626759). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Unité médicale des maladies autoinflammatoires, |
RCV000084136 | SCV000116267 | not provided | Sarcoidosis, early-onset | no assertion provided | not provided |